BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 10508858)

  • 1. Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling.
    Aguirre Ghiso JA; Kovalski K; Ossowski L
    J Cell Biol; 1999 Oct; 147(1):89-104. PubMed ID: 10508858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo.
    Aguirre-Ghiso JA; Liu D; Mignatti A; Kovalski K; Ossowski L
    Mol Biol Cell; 2001 Apr; 12(4):863-79. PubMed ID: 11294892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK).
    Aguirre-Ghiso JA; Estrada Y; Liu D; Ossowski L
    Cancer Res; 2003 Apr; 63(7):1684-95. PubMed ID: 12670923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction.
    Yebra M; Goretzki L; Pfeifer M; Mueller BM
    Exp Cell Res; 1999 Jul; 250(1):231-40. PubMed ID: 10388537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo.
    Aguirre Ghiso JA
    Oncogene; 2002 Apr; 21(16):2513-24. PubMed ID: 11971186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role of integrin alpha 5 beta 1 in urokinase (uPA)/urokinase receptor (uPAR, CD87) signaling.
    Tarui T; Andronicos N; Czekay RP; Mazar AP; Bdeir K; Parry GC; Kuo A; Loskutoff DJ; Cines DB; Takada Y
    J Biol Chem; 2003 Aug; 278(32):29863-72. PubMed ID: 12754207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner.
    Nguyen DH; Catling AD; Webb DJ; Sankovic M; Walker LA; Somlyo AV; Weber MJ; Gonias SL
    J Cell Biol; 1999 Jul; 146(1):149-64. PubMed ID: 10402467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urokinase receptors promote beta1 integrin function through interactions with integrin alpha3beta1.
    Wei Y; Eble JA; Wang Z; Kreidberg JA; Chapman HA
    Mol Biol Cell; 2001 Oct; 12(10):2975-86. PubMed ID: 11598185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenously produced urokinase-type plasminogen activator is a major determinant of the basal level of activated ERK/MAP kinase and prevents apoptosis in MDA-MB-231 breast cancer cells.
    Ma Z; Webb DJ; Jo M; Gonias SL
    J Cell Sci; 2001 Sep; 114(Pt 18):3387-96. PubMed ID: 11591826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of urokinase plasminogen activator receptor expression inhibits Erk signalling with concomitant suppression of invasiveness due to loss of uPAR-beta1 integrin complex in colon cancer cells.
    Ahmed N; Oliva K; Wang Y; Quinn M; Rice G
    Br J Cancer; 2003 Jul; 89(2):374-84. PubMed ID: 12865932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma.
    Liu D; Aguirre Ghiso J; Estrada Y; Ossowski L
    Cancer Cell; 2002 Jun; 1(5):445-57. PubMed ID: 12124174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The receptor for urokinase-type plasminogen activator regulates fibronectin matrix assembly in human skin fibroblasts.
    Monaghan E; Gueorguiev V; Wilkins-Port C; McKeown-Longo PJ
    J Biol Chem; 2004 Jan; 279(2):1400-7. PubMed ID: 14602715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of urokinase receptor expression by bikunin is associated with inhibition of upstream targets of extracellular signal-regulated kinase-dependent cascade.
    Kobayashi H; Suzuki M; Kanayama N; Nishida T; Takigawa M; Terao T
    Eur J Biochem; 2002 Aug; 269(16):3945-57. PubMed ID: 12180971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular signal-regulated kinase functions in the urokinase receptor-dependent pathway by which neutralization of low density lipoprotein receptor-related protein promotes fibrosarcoma cell migration and matrigel invasion.
    Webb DJ; Nguyen DH; Gonias SL
    J Cell Sci; 2000 Jan; 113 ( Pt 1)():123-34. PubMed ID: 10591631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of alpha5beta1 integrin conformation and function by urokinase receptor binding.
    Wei Y; Czekay RP; Robillard L; Kugler MC; Zhang F; Kim KK; Xiong JP; Humphries MJ; Chapman HA
    J Cell Biol; 2005 Jan; 168(3):501-11. PubMed ID: 15684035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary-type plasminogen activator (uPA) expression and uPA receptor localization are regulated by alpha 3beta 1 integrin in oral keratinocytes.
    Ghosh S; Brown R; Jones JC; Ellerbroek SM; Stack MS
    J Biol Chem; 2000 Aug; 275(31):23869-76. PubMed ID: 10791952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in surface urokinase receptor forces malignant cells into a protracted state of dormancy.
    Yu W; Kim J; Ossowski L
    J Cell Biol; 1997 May; 137(3):767-77. PubMed ID: 9151680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activator inhibitor 1 functions as a urokinase response modifier at the level of cell signaling and thereby promotes MCF-7 cell growth.
    Webb DJ; Thomas KS; Gonias SL
    J Cell Biol; 2001 Feb; 152(4):741-52. PubMed ID: 11266465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional relevance of urinary-type plasminogen activator receptor-alpha3beta1 integrin association in proteinase regulatory pathways.
    Ghosh S; Johnson JJ; Sen R; Mukhopadhyay S; Liu Y; Zhang F; Wei Y; Chapman HA; Stack MS
    J Biol Chem; 2006 May; 281(19):13021-13029. PubMed ID: 16510444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Domain 2 of uPAR regulates single-chain urokinase-mediated angiogenesis through β1-integrin and VEGFR2.
    Larusch GA; Merkulova A; Mahdi F; Shariat-Madar Z; Sitrin RG; Cines DB; Schmaier AH
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H305-20. PubMed ID: 23709605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.